Group 1 - The core point of the news is that Nanjing Qianjing plans to reduce its stake in Anbiping by up to 1.61% of the total share capital due to funding needs, potentially cashing out approximately 45.81 million yuan at the current share price of 30.49 yuan per share [1][2] - Nanjing Qianjing currently holds 1.61% of Anbiping's shares, and if the reduction plan is fully implemented, it may lead to a complete exit from the company [2] - Anbiping has experienced a continuous decline in net profit for four consecutive years from 2021 to 2024, with gross profit margins decreasing from 77.92% to 67.23% during the same period [2] Group 2 - In the first three quarters of 2025, Anbiping reported revenue of approximately 253 million yuan, a year-on-year decrease of 28.29%, and a net profit attributable to shareholders of approximately -10.77 million yuan, a dramatic decline of 136.34% [2] - The primary reason for the decline in total profit is attributed to a significant reduction in gross profit from the HPV product line, which decreased by 41.05 million yuan, or 79.35% [2]
清仓退场?安必平业绩承压,股东再抛减持计划